ID   RHG35_RAT               Reviewed;        1499 AA.
AC   P81128; A0A0G2KB46;
DT   04-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2016, sequence version 3.
DT   02-OCT-2024, entry version 173.
DE   RecName: Full=Rho GTPase-activating protein 35 {ECO:0000312|RGD:1308738};
DE   AltName: Full=GAP-associated protein p190;
DE   AltName: Full=Glucocorticoid receptor DNA-binding factor 1;
GN   Name=Arhgap35 {ECO:0000312|RGD:1308738};
GN   Synonyms=Grlf1, P190A {ECO:0000303|PubMed:9852136},
GN   p190ARHOGAP {ECO:0000303|PubMed:9852136};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA], PROTEIN SEQUENCE OF 379-391; 491-506 AND
RP   1304-1322, PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=1581965; DOI=10.1016/0092-8674(92)90454-k;
RA   Settleman J., Narasimhan V., Foster L.C., Weinberg R.A.;
RT   "Molecular cloning of cDNAs encoding the GAP-associated protein p190:
RT   implications for a signaling pathway from ras to the nucleus.";
RL   Cell 69:539-549(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   FUNCTION, GTP-BINDING, AND MUTAGENESIS OF SER-36 AND ARG-1284.
RX   PubMed=9852136; DOI=10.1074/jbc.273.51.34631;
RA   Tatsis N., Lannigan D.A., Macara I.G.;
RT   "The function of the p190 Rho GTPase-activating protein is controlled by
RT   its N-terminal GTP binding domain.";
RL   J. Biol. Chem. 273:34631-34638(1998).
RN   [4]
RP   FUNCTION, MUTAGENESIS OF SER-1451 AND 1476-SER--SER-1483, AND
RP   PHOSPHORYLATION.
RX   PubMed=20439493; DOI=10.1128/mcb.01178-09;
RA   Pullikuth A.K., Catling A.D.;
RT   "Extracellular signal-regulated kinase promotes Rho-dependent focal
RT   adhesion formation by suppressing p190A RhoGAP.";
RL   Mol. Cell. Biol. 30:3233-3248(2010).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-589; SER-975; SER-985;
RP   SER-1134 AND SER-1179, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Rho GTPase-activating protein (GAP). Binds several acidic
CC       phospholipids which inhibits the Rho GAP activity to promote the Rac
CC       GAP activity (PubMed:20439493, PubMed:9852136). This binding is
CC       inhibited by phosphorylation by PRKCA (By similarity). Involved in cell
CC       differentiation as well as cell adhesion and migration, plays an
CC       important role in retinal tissue morphogenesis, neural tube fusion,
CC       midline fusion of the cerebral hemispheres and mammary gland branching
CC       morphogenesis (PubMed:20439493, PubMed:9852136). Transduces signals
CC       from p21-ras to the nucleus, acting via the ras GTPase-activating
CC       protein (GAP) (By similarity). Transduces SRC-dependent signals from
CC       cell-surface adhesion molecules, such as laminin, to promote neurite
CC       outgrowth. Regulates axon outgrowth, guidance and fasciculation (By
CC       similarity). Modulates Rho GTPase-dependent F-actin polymerization,
CC       organization and assembly, is involved in polarized cell migration and
CC       in the positive regulation of ciliogenesis and cilia elongation (By
CC       similarity). During mammary gland development, is required in both the
CC       epithelial and stromal compartments for ductal outgrowth (By
CC       similarity). Represses transcription of the glucocorticoid receptor by
CC       binding to the cis-acting regulatory sequence 5'-
CC       GAGAAAAGAAACTGGAGAAACTC-3'; this function is however unclear and would
CC       need additional experimental evidences (By similarity).
CC       {ECO:0000250|UniProtKB:Q91YM2, ECO:0000250|UniProtKB:Q9NRY4,
CC       ECO:0000269|PubMed:20439493, ECO:0000269|PubMed:9852136}.
CC   -!- SUBUNIT: Interacts with RASA1 (By similarity). Interacts with the
CC       general transcription factor GTF2I, the interaction sequesters GTF2I in
CC       the cytoplasm (By similarity). {ECO:0000250|UniProtKB:Q91YM2,
CC       ECO:0000250|UniProtKB:Q9NRY4}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000250|UniProtKB:Q91YM2}. Cytoplasm {ECO:0000269|PubMed:1581965}.
CC       Nucleus {ECO:0000269|PubMed:1581965}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q91YM2}. Note=In response to integrins and SDC4
CC       and upon phosphorylation by PKC, relocalizes from the cytoplasm to
CC       regions of plasma membrane ruffling where it colocalizes with
CC       polymerized actin. {ECO:0000250|UniProtKB:Q91YM2}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- DOMAIN: N-terminal part (1-266) has GTPase activity. Required for
CC       proper cellular localization. {ECO:0000250|UniProtKB:Q91YM2}.
CC   -!- DOMAIN: The pG1 pseudoGTPase domain does not bind GTP.
CC       {ECO:0000250|UniProtKB:Q6NU25}.
CC   -!- PTM: Phosphorylation of Tyr-1105 by PTK6 promotes the association with
CC       RASA1, inactivating RHOA while activating RAS. Phosphorylation at Tyr-
CC       308 by PDGFRA inhibits binding to GTF2I (By similarity). Phosphorylated
CC       by PRKCA at Ser-1221 and Thr-1226, induces relocalization from the
CC       cytoplasm to regions of plasma membrane ruffling and prevents the
CC       binding and substrate specificity regulation by phospholipids (By
CC       similarity). In brain, phosphorylated by FYN and SRC (By similarity).
CC       During focal adhesion formation, phosphorylated by MAPK1 and MAPK3 at
CC       the C-terminal region, probably at Ser-1451, Ser-1476, Thr-1480 and
CC       Ser-1483. Phosphorylation by MAPK1 and MAPK3 inhibits GAP function and
CC       localizes ARGHAP35 away from newly forming focal adhesions and stress
CC       fibers in cells spreading on fibronectin (PubMed:20439493).
CC       Phosphorylation at Ser-1476 and Thr-1480 by GSK3B requires priming by
CC       MAPK and inhibits RhoGAP activity and modulates polarized cell
CC       migration (By similarity). {ECO:0000250|UniProtKB:Q91YM2,
CC       ECO:0000250|UniProtKB:Q9NRY4, ECO:0000269|PubMed:20439493}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94721; -; NOT_ANNOTATED_CDS; Genomic_RNA.
DR   EMBL; AABR07002647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07002648; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A38218; A38218.
DR   RefSeq; NP_001258061.1; NM_001271132.1.
DR   RefSeq; XP_006228474.1; XM_006228412.3.
DR   RefSeq; XP_008757141.1; XM_008758919.1.
DR   PDB; 5IRC; X-ray; 1.72 A; A/B=1242-1439.
DR   PDB; 6D4G; X-ray; 2.80 A; A/B=1-266.
DR   PDBsum; 5IRC; -.
DR   PDBsum; 6D4G; -.
DR   AlphaFoldDB; P81128; -.
DR   BMRB; P81128; -.
DR   SMR; P81128; -.
DR   STRING; 10116.ENSRNOP00000021223; -.
DR   iPTMnet; P81128; -.
DR   PhosphoSitePlus; P81128; -.
DR   jPOST; P81128; -.
DR   PaxDb; 10116-ENSRNOP00000021223; -.
DR   Ensembl; ENSRNOT00000090519.2; ENSRNOP00000075649.1; ENSRNOG00000015852.5.
DR   Ensembl; ENSRNOT00055028949; ENSRNOP00055023301; ENSRNOG00055017051.
DR   Ensembl; ENSRNOT00060037074; ENSRNOP00060030580; ENSRNOG00060021410.
DR   Ensembl; ENSRNOT00065054241; ENSRNOP00065044625; ENSRNOG00065031476.
DR   GeneID; 306400; -.
DR   KEGG; rno:306400; -.
DR   UCSC; RGD:1308738; rat.
DR   AGR; RGD:1308738; -.
DR   CTD; 2909; -.
DR   RGD; 1308738; Arhgap35.
DR   eggNOG; KOG4271; Eukaryota.
DR   GeneTree; ENSGT01030000234635; -.
DR   InParanoid; P81128; -.
DR   OMA; IVMCLLC; -.
DR   OrthoDB; 5405671at2759; -.
DR   Reactome; R-RNO-416550; Sema4D mediated inhibition of cell attachment and migration.
DR   Reactome; R-RNO-8849471; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases.
DR   Reactome; R-RNO-8980692; RHOA GTPase cycle.
DR   Reactome; R-RNO-9013026; RHOB GTPase cycle.
DR   Reactome; R-RNO-9013148; CDC42 GTPase cycle.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   Reactome; R-RNO-9013404; RAC2 GTPase cycle.
DR   Reactome; R-RNO-9013405; RHOD GTPase cycle.
DR   Reactome; R-RNO-9013406; RHOQ GTPase cycle.
DR   Reactome; R-RNO-9013408; RHOG GTPase cycle.
DR   Reactome; R-RNO-9013409; RHOJ GTPase cycle.
DR   Reactome; R-RNO-9696264; RND3 GTPase cycle.
DR   Reactome; R-RNO-9696270; RND2 GTPase cycle.
DR   Reactome; R-RNO-9696273; RND1 GTPase cycle.
DR   PRO; PR:P81128; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000015852; Expressed in frontal cortex and 19 other cell types or tissues.
DR   ExpressionAtlas; P81128; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; ISO:RGD.
DR   GO; GO:0036064; C:ciliary basal body; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0032794; F:GTPase activating protein binding; IPI:RGD.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0005543; F:phospholipid binding; ISS:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0007413; P:axonal fasciculation; ISS:UniProtKB.
DR   GO; GO:0043010; P:camera-type eye development; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; ISS:UniProtKB.
DR   GO; GO:0030950; P:establishment or maintenance of actin cytoskeleton polarity; ISS:UniProtKB.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0030879; P:mammary gland development; ISS:UniProtKB.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; ISO:RGD.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; ISO:RGD.
DR   GO; GO:0001843; P:neural tube closure; ISO:RGD.
DR   GO; GO:0097485; P:neuron projection guidance; ISS:UniProtKB.
DR   GO; GO:0045724; P:positive regulation of cilium assembly; ISS:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0008064; P:regulation of actin polymerization or depolymerization; ISS:UniProtKB.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:0008361; P:regulation of cell size; IBA:GO_Central.
DR   GO; GO:0007266; P:Rho protein signal transduction; ISO:RGD.
DR   GO; GO:0044319; P:wound healing, spreading of cells; ISS:UniProtKB.
DR   CDD; cd22221; pseudoGTPaseD_p190RhoGAP-A; 1.
DR   CDD; cd04373; RhoGAP_p190; 1.
DR   Gene3D; 1.10.10.440; FF domain; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 1.10.555.10; Rho GTPase activation protein; 1.
DR   InterPro; IPR002713; FF_domain.
DR   InterPro; IPR036517; FF_domain_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR039007; pG1.
DR   InterPro; IPR051978; Rho-GAP_domain.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR032835; RhoGAP-FF1.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR045786; RhoGAP_pG1_pG2.
DR   InterPro; IPR039006; RhoGAP_pG2.
DR   InterPro; IPR001806; Small_GTPase.
DR   PANTHER; PTHR46005; RHO GTPASE-ACTIVATING PROTEIN 190; 1.
DR   PANTHER; PTHR46005:SF1; RHO GTPASE-ACTIVATING PROTEIN 35; 1.
DR   Pfam; PF00071; Ras; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF16512; RhoGAP-FF1; 1.
DR   Pfam; PF19518; RhoGAP_pG1_pG2; 1.
DR   PRINTS; PR00449; RASTRNSFRMNG.
DR   SMART; SM00441; FF; 4.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF81698; FF domain; 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51676; FF; 4.
DR   PROSITE; PS51852; PG1; 1.
DR   PROSITE; PS51853; PG2; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; DNA-binding; GTP-binding; GTPase activation;
KW   Lipid-binding; Membrane; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..1499
FT                   /note="Rho GTPase-activating protein 35"
FT                   /id="PRO_0000056732"
FT   DOMAIN          270..327
FT                   /note="FF 1"
FT   DOMAIN          368..422
FT                   /note="FF 2"
FT   DOMAIN          429..483
FT                   /note="FF 3"
FT   DOMAIN          485..550
FT                   /note="FF 4"
FT   DOMAIN          592..767
FT                   /note="pG1 pseudoGTPase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01199"
FT   DOMAIN          783..947
FT                   /note="pG2 pseudoGTPase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01200"
FT   DOMAIN          1249..1436
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   REGION          1..266
FT                   /note="Has GTPase activity, required for proper
FT                   localization"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   REGION          1124..1148
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1177..1212
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1213..1236
FT                   /note="Required for phospholipid binding and regulation of
FT                   the substrate preference"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   REGION          1446..1499
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1124..1139
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1182..1196
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1470..1485
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         28
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         33..37
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         52
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         56
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         95..97
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         201..203
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         229..231
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         308
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         589
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         770
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         773
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         970
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         975
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         985
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1072
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1087
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1105
FT                   /note="Phosphotyrosine; by ABL2 and PTK6"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1134
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MOD_RES         1150
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1176
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1221
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1226
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1472
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MOD_RES         1476
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MOD_RES         1480
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MOD_RES         1483
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MUTAGEN         36
FT                   /note="S->N: Disrupts GTP-binding. No direct effect on GAP
FT                   activity 'in vitro' but affects the activity regulation 'in
FT                   vivo'."
FT                   /evidence="ECO:0000269|PubMed:9852136"
FT   MUTAGEN         1284
FT                   /note="R->A: Abolishes GAP activity."
FT                   /evidence="ECO:0000269|PubMed:9852136"
FT   MUTAGEN         1451
FT                   /note="S->A: Abolishes phosphorylation by MAPK, increases
FT                   functional activity and enhances retention in peripheral
FT                   membranes; when associated with 1476-A--A-1483."
FT                   /evidence="ECO:0000269|PubMed:20439493"
FT   MUTAGEN         1476..1483
FT                   /note="SPPPTPQS->APPPAPQA: Abolishes phosphorylation by
FT                   MAPK, increases functional activity and enhances retention
FT                   in peripheral membranes; when associated with A-1451."
FT                   /evidence="ECO:0000269|PubMed:20439493"
FT   STRAND          15..19
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   TURN            25..30
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           35..43
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   TURN            47..49
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           60..63
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   TURN            66..70
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   STRAND          72..79
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   STRAND          91..96
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   TURN            102..104
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           116..120
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   STRAND          123..126
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           136..138
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           142..144
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           151..153
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   STRAND          159..165
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   TURN            169..171
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           174..190
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   STRAND          195..200
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           207..218
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   STRAND          224..227
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   TURN            230..233
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   HELIX           236..251
FT                   /evidence="ECO:0007829|PDB:6D4G"
FT   STRAND          1245..1249
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1251..1254
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   STRAND          1257..1259
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1263..1275
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   TURN            1280..1284
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1289..1301
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   TURN            1307..1309
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1314..1327
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   STRAND          1328..1330
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1335..1345
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1350..1361
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1366..1383
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1386..1389
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1393..1398
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1401..1405
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1412..1416
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1419..1430
FT                   /evidence="ECO:0007829|PDB:5IRC"
FT   HELIX           1432..1436
FT                   /evidence="ECO:0007829|PDB:5IRC"
SQ   SEQUENCE   1499 AA;  170480 MW;  B3AEBD920E98B310 CRC64;
     MMMARKQDVR IPTYNISVVG LSGTEKEKGQ CGIGKSCLCN RFVRPSADEF HLDHTSVLST
     SDFGGRVVNN DHFLYWGEVS RSLEDCVECK MHIVEQTEFI DDQTFQPHRS TALQPYIKRA
     AATKLASAEK LMYFCTDQLG LEQDFEQKQM PDGKLLVDGF LLGIDVSRGM NRNFDDQLKF
     VSNLYNQLAK TKKPIVIVLT KCDEGVERYI RDAHTFALSK KNLQVVETSA RSNVNVDLAF
     STLVQLIDKS RGKTKIIPYF EALKQQSQQI ATAKDKYEWL VSRIVKSHNE NWLSVSRKMQ
     ASPEYQDYVY LEGTQKAKKL FLQHIHRLKH EHIERRRKLY LAALPLAFEA LIPNLDEVDH
     LSCIKAKKLL ETKPEFLKWF VVLEETPWDE TSHIDNMENE RIPFDLMDTV PAEQLYETHL
     EKLRNERKRA EMRRAFKENL ETSPFITPGK PWEEARSFIM NEDFYQWLEE SVYMDIYGKH
     QKQIIDRAKE EFQELLLEYS ELFYELELDA KPSKEKMGVI QDVLGEEQRF KALQKLQAER
     DALILKHIHF VYHPTKETCP SCPACVDAKI EHLISSRFIR PSDRNQKNSL SDPNIDRINL
     VILGKDGLAR ELANEIRALC TNDDKYVIDG KMYELSLRPI EGNVRLPVNS FQTPTFQPHG
     CLCLYNSKES LSYVVESIEK SRESTLGRRD NHLVHLPLTL ILVNKRGDTS GETLHSLIQQ
     GQQIASKLQC VFLDPASAGI GYGRNINEKQ ISQVLKGLLD SKRNLNLVSS TASIKDLADV
     DLRIVMCLMC GDPFSADDIL SPVLQSQTCK SSHCGSSNSV LLELPIGVHK KRIELSVLSY
     HSSFSIRKSR LVHGYIVFYS AKRKASLAML RAFLCEVQDI IPIQLVALTD GAIDVLDNDL
     SREQLTEGEE IAQEIDGRFT SIPCSQPQHK LELFHPFFKD VVEKKNIIEA THMYDNVAEA
     CSTTEEVFNS PRAGSPLCNS NLQDSEEDVE PPSYHLFRED ATLPSLSKDH SKFSMELEGN
     DGLSFIMSNF ESKLNNKVPP PVKPKPPVHF EITKDLSYLD QGHREGQRKS MSSSPWMPQD
     GFDPSDYAEP MDAVVKPRNE EENIYSVPHD STQGKIITIR NINKAQSNGS GNGSDSEMDT
     SSLERGRKVS AVSKPVLYRT RCTRLGRFAS YRTSFSVGSD DELGPIRKKE EDQASQGYKG
     DNAVIPYETD EDPRRRNILR SLRRNTKKPK PKPRPSITKA TWESNYFGVP LTTVVTPEKP
     IPIFIERCIE YIEATGLSTE GIYRVSGNKS EMESLQRQFD QDHNLDLAEK DFTVNTVAGA
     MKSFFSELPD PLVPYSMQID LVEAHKINDR EQKLHALKEV LKKFPKENHE VFKYVISHLN
     RVSHNNKVNL MTSENLSICF WPTLMRPDFS SMDALTATRS YQTIIELFIQ QCPFFFYNRP
     ISEPPGAAPG SPSAMAPTVP FLTSTPATSQ PSPPQSPPPT PQSPMQPLLS SQLQAEHTL
//
